16th EBF Open Symposium
One year into ICH M10 - Keeping our finger on the pulse
14 November 2023 (Workshop independent from 16th OS)
Science Winning the Race
15-17 November 2023
In Unity Lies Power; Building a Better Bioanalytical World Together
YSS Final Program
for a downloadble PDF version of the presentation click here
08:30 | 08:35 | Welcome and Introduction |
08:35 | 10:15 | session 1: Overcoming Bioanalytical Mysteries |
08:35 | 08:55 | Farjana Mahammed (GlaxoSmithKline) |
Analytical Method Transfer – Are our methods Smooth Sailing or Slowly Sinking? | ||
08:55 | 09:15 | Patrick Heath (Covance) |
Overcoming soluble target interference in an Immunogenicty screening assay incorporating an immunodepletion step using streptavidin magnetic beads. | ||
09:15 | 09:35 | Stacey Casswell (Envigo) |
Challenges and considerations in the use of a immunoassay method for the detection of TSH, T3 and T4 for use in reproduction/developmental toxcology studies. | ||
09:35 | 09:55 | Jana Zemenová (University of Prague) |
Lipopeptides – challenges in bioanalysis of novel pharmaceutical targets via LC-MS and immunomethods | ||
09:55 | 10:15 | Jason Pembroke (LGC) |
Bioanalytical Challenges of Chelating Compound | ||
10:15 | 10:45 | Coffee break |
10:45 | 12:15 | Project YSS: Together we succeed: feedback from YSS collaboration |
projects | ||
10:45 | 11:30 | Feedback from the pre-competitive collaborative work between |
AstraZeneca, Charles River, Covance, GlaxoSmithKline, Ghent University, Janssen R&D LGC and Q2-solutions on Liquid Microsampling | ||
Moderators: Aline Swinnen and Sheelan Ahmad (for EBF-YSS) | ||
11:30 | 12:15 | Feedback from the pre-competitive collaborative work between |
AstraZeneca, Charles River, LGC MedImmune and Novimmune SA on multiplex biomarker assay performance | ||
Moderators: Jonathan Paraskos and Sufyan Maqbool (for EBF-YSS) | ||
12:15 | 13:15 | Lunch break |
13:15 | 14:55 | Session 2: Transforming Bioanalysis Through Innovation |
13:15 | 13:35 | Mikko Hölttä (AstraZeneca) |
Bioanalytical strategies for quantification of intact RNA and its metabolites | ||
13:35 | 13:55 | Sofie Velghe (University of Ghent) |
Fully automated direct extraction and analysis of dried blood spots for the determination of five anti-epileptic drugs and one active metabolite | ||
13:55 | 14:15 | Yannick Van Wanseele (Free University of Brussels) |
The application of superchargers to increase nanoUHPLC-MS/MS method sensitivity for quantification of the neuropeptide neuromedin U | ||
14:15 | 14:35 | Emily Bell (Charles River) |
Immunocapture as a Viable Sample Preparation Technology in the Transition between Pre-Clinical and Clinical Bioanalysis | ||
14:35 | 14:55 | Kees Pelster (PRA Health Sciences) |
Validation of capillary microsampling assays: a practical point of view | ||
14:55 | 15:15 | Tea break |
15:15 | 17:00 | Session 3: Ask The Experts |
15:15 | 15:35 | Morgan Evans (Intertek) |
Technologies of Immunogenicity: An ADA case study | ||
15:35 | 15:55 | Sijranke Post (PRA Health Sciences) |
The challenges in validating a 6-color T-, B- and NK-cell flow cytometry assay in human whole blood using multiple blood collections tubes as well as manual and automatic sample processing. | ||
15:55 | 16:15 | Adeline Besson (Novimmune SA) |
Development and validation of a novel biomarker assay to support the development of a biologic | ||
16:15 | 16:35 | Godknows Hlatshwayo (LGC) |
Case Study: Immunoassay Development for a gene therapy drug | ||
16:35 | 16:55 | Sara Capiau (University of Ghent) |
Development and validation of an ICP-MS method to quantitatively determine cobalt in volumetric absorptive microsampling (VAMS) devices for the follow-up of metal-on-metal prosthesis patients. | ||
16:55 | 17:00 | 2016 Best Presenter prize and Wrap-up |
17:00 | 17:00 | Adjourn |